Background: Hepatitis B virus (HBV) reactivation is increasing, as rituximab has become widely used for B-cell lymphoma. Thus, prevention and management of HBV reactivation are important in HBV-endemic areas. Methods: Hepatitis B virus (HBV) reactivation in HBV surface antigen (HBsAg)-positive patients and HBsAg-negative/HBV core antibody (HBcAb)-positive patients who received rituximab-containing chemotherapy was investigated by the Asia Lymphoma Study Group via retrospective (n = 340), and the results were compared to cross-sectional analysis with patients who were prospectively monitored in a single institute (n = 127). The goal of the study was to define the frequency of HBV reactivation and the efficacy of antiviral prophylaxis. ...
Infection rate of hepatitis B virus (HBV) in our country remains high. Many patients showed combined...
Background/Aims: Tumor necrosis factor-? (TNF-?) inhibitors and ustekunimab are widely used in autoi...
A 72-year-old female negative for hepatitis B surface antigen (HBsAg) and positive for antibody to h...
BACKGROUND: Hepatitis B virus (HBV) reactivation is increasing, as rituximab has become widely used ...
[[abstract]]Background and Aims: Prophylactic antiviral therapy was recommended to prevent HBV react...
Backgound: A significant proportion of hepatitis B surface antigen (HBsAg) negative/anti-hepatitis B...
Fatal hepatitis B virus (HBV) reactivation in lymphoma patients with "resolved" HBV infect...
Introduction: Targeted therapies have gained popularity in the treatment of several oncologic and im...
IMPORTANCE Hepatitis B virus (HBV) reactivation is a serious complication for patients with lymphoma...
[[abstract]]Background and Aims: Hepatitis B virus (HBV) reactivation can occur to 10–40% of lymphom...
[[abstract]]BACKGROUND AND AIMS: Absence or low anti-hepatitis B (HBV) surface antibody (anti-HBs) i...
Hepatitis B virus reactivation (HBVr) can develop in HBV surface antigen (HBsAg) positive or HBsAg-n...
AIM: To present the characteristics and the course of a series of anti- hepatitis B virus core antib...
Introduction: Rituximab (RTX), a chimeric mouse anti-human CD20 monoclonal antibody, is indicated fo...
[[abstract]]Fatal hepatitis B virus (HBV) reactivation in lymphoma patients with 'resolved' HBV infe...
Infection rate of hepatitis B virus (HBV) in our country remains high. Many patients showed combined...
Background/Aims: Tumor necrosis factor-? (TNF-?) inhibitors and ustekunimab are widely used in autoi...
A 72-year-old female negative for hepatitis B surface antigen (HBsAg) and positive for antibody to h...
BACKGROUND: Hepatitis B virus (HBV) reactivation is increasing, as rituximab has become widely used ...
[[abstract]]Background and Aims: Prophylactic antiviral therapy was recommended to prevent HBV react...
Backgound: A significant proportion of hepatitis B surface antigen (HBsAg) negative/anti-hepatitis B...
Fatal hepatitis B virus (HBV) reactivation in lymphoma patients with "resolved" HBV infect...
Introduction: Targeted therapies have gained popularity in the treatment of several oncologic and im...
IMPORTANCE Hepatitis B virus (HBV) reactivation is a serious complication for patients with lymphoma...
[[abstract]]Background and Aims: Hepatitis B virus (HBV) reactivation can occur to 10–40% of lymphom...
[[abstract]]BACKGROUND AND AIMS: Absence or low anti-hepatitis B (HBV) surface antibody (anti-HBs) i...
Hepatitis B virus reactivation (HBVr) can develop in HBV surface antigen (HBsAg) positive or HBsAg-n...
AIM: To present the characteristics and the course of a series of anti- hepatitis B virus core antib...
Introduction: Rituximab (RTX), a chimeric mouse anti-human CD20 monoclonal antibody, is indicated fo...
[[abstract]]Fatal hepatitis B virus (HBV) reactivation in lymphoma patients with 'resolved' HBV infe...
Infection rate of hepatitis B virus (HBV) in our country remains high. Many patients showed combined...
Background/Aims: Tumor necrosis factor-? (TNF-?) inhibitors and ustekunimab are widely used in autoi...
A 72-year-old female negative for hepatitis B surface antigen (HBsAg) and positive for antibody to h...